Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Avil
2. Bimaleate, Pheniramine
3. Daneral
4. Histapyridamine
5. Maleate, Pheniramine
6. Pheniramine
7. Pheniramine Bimaleate
8. Propheniramine
9. Prophenpyridamine
1. 132-20-7
2. Inhiston
3. Trimetose
4. Daneral
5. Naphcon A
6. Pheniramine Hydrogen Maleate
7. Pheniramine Maleate Salt
8. Prophenpyridamine Maleate
9. Antolozine
10. Fervex
11. Pheniramine (maleate)
12. 1-phenyl-1-(2-pyridyl)-3-dimethylaminopropane Maleate
13. Nsc-757270
14. Chebi:31990
15. Nyw905655b
16. Pm-241
17. Avil-retard
18. N,n-dimethyl-3-phenyl-3-(2-pyridyl)propylamine Hydrogen Maleate
19. 2-pyridinepropanamine, N,n-dimethyl-gamma-phenyl-, (2z)-2-butenedioate (1:1)
20. Pheniramine Maleate [usan]
21. Ccris 6265
22. Sr-01000075263
23. Einecs 205-051-4
24. Ho 11513
25. N,n-dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine Maleate
26. Unii-nyw905655b
27. Pheniramine Maleate [usan:usp]
28. Prestwick_769
29. Mfcd00079250
30. 2-(alpha-(2-(dimethylamino)ethyl)benzyl)pyridine, Maleate
31. 2-(alpha-(2-(dimethylamino)ethyl)benzyl)pyridine, Bimaleate
32. Phenyl(2-pyridyl)(beta-n,n-dimethylaminomethyl) Methane Maleate
33. 1-(n,n-dimethylamino)-3-(phenyl-3-alpha-pyridyl)propane Maleate
34. 2-pyridinepropanamine, N,n-dimethyl-gamma-phenyl-, (z)-2-butenedioate (1:1)
35. Chembl1653
36. Schembl25318
37. Mls001148181
38. Spectrum1500478
39. Pheniramine Maleate (jan/usp)
40. 2-(alpha-(2-dimethylaminoethyl)benzyl)pyridine Bimaleate
41. Pheniramine Maleate [mi]
42. Hms500l17
43. Pheniramine Maleate [jan]
44. (z)-but-2-enedioic Acid;n,n-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine
45. Hms1568k19
46. Hms1920f22
47. Hms2091p04
48. Hms2095k19
49. Hms2232i20
50. Hms3263e03
51. Hms3712k19
52. Hms3885m20
53. Pharmakon1600-01500478
54. Pheniramine Maleate [vandf]
55. Hy-b0971
56. Pheniramine Maleate [mart.]
57. Tox21_500981
58. Ccg-39109
59. Nsc757270
60. Pheniramine Maleate [usp-rs]
61. Pheniramine Maleate [who-dd]
62. Pyridine, 2-(alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1)
63. (2z)-but-2-enedioic Acid; Dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine
64. Akos026749878
65. Cs-4460
66. Lp00981
67. Nsc 757270
68. 2-pyridinepropanamine, N,n-dimethyl-.gamma.-phenyl-, (2z)-2-butenedioate (1:1)
69. 2-pyridinepropanamine, N,n-dimethyl-.gamma.-phenyl-, (z)-2-butenedioate (1:1)
70. Ncgc00094281-01
71. Ncgc00094281-02
72. Ncgc00094281-03
73. Ncgc00094281-04
74. Ncgc00094281-05
75. Ncgc00261666-01
76. Pheniramine Maleate [ep Impurity]
77. Pheniramine Maleate [orange Book]
78. Ac-15941
79. As-12971
80. Bp166247
81. Pheniramine Maleate [ep Monograph]
82. Smr000653458
83. Pheniramine Maleate [usp Monograph]
84. Eu-0100981
85. P2271
86. S4045
87. Sw196908-3
88. Visine-a Component Pheniramine Maleate
89. Naphcon-a Component Pheniramine Maleate
90. D01174
91. P 6902
92. Pheniramine Maleate Component Of Opcon-a
93. Pheniramine Maleate Component Of Visine-a
94. Pheniramine Maleate Component Of Naphcon-a
95. J-006144
96. Sr-01000075263-1
97. Sr-01000075263-4
98. Sr-01000075263-7
99. Q27114744
100. Benzenepropanoic Acid, 4-(1-methylethyl)-.alpha.-oxo-
101. 1-phenyl-1-(2-pyridyl)-3-dimethaminopropane Maleinate
102. 2-(.alpha.-(2-dimethylaminoethyl)benzyl)pyridine Bimaleate
103. Pheniramine Maleate, European Pharmacopoeia (ep) Reference Standard
104. 2-(.alpha.-(2-(dimethylamino)ethyl)benzyl)pyridine Bimaleate
105. Pheniramine Maleate, United States Pharmacopeia (usp) Reference Standard
106. Pyridine, 2-(.alpha.-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1)
107. 155683-11-7
Molecular Weight | 356.4 g/mol |
---|---|
Molecular Formula | C20H24N2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 356.17360725 g/mol |
Monoisotopic Mass | 356.17360725 g/mol |
Topological Polar Surface Area | 90.7 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 340 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?